QA: Kura Oncology Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001422143_2022_Kura_Oncology_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001422143')"}

Graph

Absolute values for 0001422143, Kura Oncology Inc.

  xvar xval
0 AssetsCurrent 522,289,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,673,000
3 remainder_Assets 9,089,000
4 LiabilitiesCurrent 22,455,000
5 LiabilitiesNoncurrent 4,987,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 46,537,000
9 ResearchAndDevelopmentExpense 84,721,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 792,000
13 remainder_ComprehensiveNetIncome -1,835,000
  yvar yval
0 Assets 534,051,000
1 Liabilities 27,442,000
2 Expenses 131,258,000
3 Revenues 0
4 StockholdersEquity 506,609,000
5 NetIncome -130,466,000
6 ComprehensiveNetIncome -131,383,500
7 BaseVar 347,689,000
8 EconomicCapitalRatio 2.64

Edgar->Model Mapping

Feature Distribution

Change over Time